Dr. Lavine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8110 Birmingham Way
San Diego, CA 92123Phone+1 858-966-4003- Is this information wrong?
Education & Training
- University of California San Diego School of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 1985 - Present
- NY State Medical License 2010 - 2021
- MA State Medical License 1991 - 1996
Awards, Honors, & Recognition
- AGA-F AGA, 2021-2023
- AASLD-F AASLD, 2008, 2023
Publications & Presentations
PubMed
- 4360 citationsThe diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi
Hepatology. 2018-01-01 - 2209 citationsPioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisArun J. Sanyal, Naga Chalasani, Kris V. Kowdley, Arthur J. McCullough, Anna Mae Diehl
The New England Journal of Medicine. 2010-05-06 - 1579 citationsFarnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander-Tetri, Rohit Loomba, Arun J. Sanyal, Joel E. Lavine, Mark L. Van Natta
Lancet. 2015-03-14
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: